MicroRNA-378g (miR-378g)

MicroRNA-378g (miR-378g; also hsa-mir-378g or MIR378G) is annotated as a member of the miR-378 microRNA family, a group of small non-coding RNAs involved in post-transcriptional regulation of gene expression. While several isoforms in this family (such as miR-378a) have been documented with roles in metabolism, angiogenesis, cancer, and cardiovascular diseases[1][4], there is currently no authoritative literature specifically describing the function, expression, or therapeutic relevance of miR-378g. Most published research and clinical relevance concern miR-378a and not miR-378g. In most biological and medical databases, "miR-378g" appears as a predicted or putative miRNA with limited or zero functional annotation. Key context: - Extensive review articles and primary research focus on miR-378a or the miR-378 family as a whole, but miR-378g itself is not substantiated as a target of current therapeutic or diagnostic efforts[1][4]. - There is widespread confusion and ambiguity in the miR-378 family nomenclature, which can lead to errors when inferring properties of specific isoforms like miR-378g[1]. - No known drugs, biomarkers, or mechanisms of action are established specifically for miR-378g. Summary: - MicroRNA-378g is currently not recognized as a validated or therapeutically relevant target. Caution should be taken in distinguishing it from miR-378a, which is functionally and clinically characterized. The entry might be a misattribution, a predicted microRNA without biological validation, or simply an under-studied target[1][4]. If your query is focused on the well-characterized, biologically and clinically relevant miR-378a ("microRNA-378a"), please clarify, since most functional data pertains to that member of the family instead of miR-378g.

Other names

hsa-mir-378gMIR378GmiR-378g

Not established for miR-378g; in general, microRNAs repress gene expression by binding mRNAs